SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001562371-15-000003
Filing Date
2015-05-05
Accepted
2015-05-05 15:43:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D sarepta_13d.htm SC 13D 24881
  Complete submission text file 0001562371-15-000003.txt   26408
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Subject) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-54847 | Film No.: 15832703
SIC: 2834 Pharmaceutical Preparations

Mailing Address 285 MARGALITA DRIVE SAN RAFAEL CA 94901
Business Address
Barry Richard (Filed by) CIK: 0001562371 (see all company filings)

Type: SC 13D